Advanced search for publications

Enter your keywords

Bortezimib for thrombotic thrombocytopenic purpura

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Anakinra for immuno-oncologic meningoencephalitis

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

EBV cytotoxic T-cells for lymphoproliferative disease

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Daratumumab for steroid-sensitive nephrotic syndrome

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Baricitinib for haploinsufficiency of A20

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Benralizumab combination therapy for severe asthma

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Naloxegol and naldemedine for post-operative ileus following radical cystectomy

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Intralesional rituximab for localised pemphigus

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]

Adalimumab, infliximab, and ustekinumab in pyoderma gangrenosum

RDTC D&T reviews are prepared in response to specific requests. They are intended for use by drug and therapeutics groups or equivalent committees, to support the review of applications to use a treatment in an individual or cohort. They are not intended to be used as standalone publications A copy of this review is available […]